MedTrace Logo

Circulating Tumor Cells to Guide Chemotherapy for Metastatic Breast Cancer

NCT01349842 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 265

Last updated 2025-11-24

No results posted yet for this study

Summary

Evaluation of the use of Circulating tumour Cells to guide chemotherapy from the 3rd line of chemotherapy for metastatic breast cancer.

Conditions

  • Breast Cancer Ductal Infiltrating Metastatic

Interventions

BIOLOGICAL

Blood sampling

20ml of patient peripherical blood will be collected

OTHER

Usual clinical and radiological criteria

Clinical examination, tumoral evaluation

Sponsors & Collaborators

  • Institut Curie

    lead OTHER

Principal Investigators

  • PIERGA Jean-Yves, MD · Institut Curie

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-02
Primary Completion
2016-01-31
Completion
2018-11-06

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01349842 on ClinicalTrials.gov